Zydus Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

2,371.30

2,159.30

2,955.70

2,579.30

2,086.90

Operating profit

699.10

649.40

1,141.00

772.50

458.60

Interest

103.90

90.90

89.70

85.00

88.50

Gross profit

702.00

1,093.00

1,133.70

938.70

506.40

EPS (Rs)

4.45

7.95

7.72

4.85

2.53

Other income

106.80

534.50

82.40

251.20

136.30

Stock adjustment

24.50

-98.10

28.10

-14.70

38.70

Raw material

681.60

705.90

876.70

806.70

626.10

Power and fuel

-

-

-

-

-

Employee expenses

373.00

377.70

351.70

353.10

326.10

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

593.10

524.40

558.20

661.70

637.40

Provisions made

-

-

-

-

-

Depreciation

127.70

124.90

121.20

119.90

121.60

Taxation

123.90

163.10

231.60

124.30

128.90

Net profit / loss

450.40

805.00

780.90

490.70

255.90

Extra ordinary item

-

-

-

-203.80

-

Prior year adjustments

-

-

-

-

-

Equity capital

101.20

101.20

101.20

101.20

101.20

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

29.48

30.07

38.60

29.95

21.98

GPM (%)

28.33

40.57

37.32

33.16

22.78

NPM (%)

18.18

29.88

25.70

17.34

11.51